retatrutide safety profile clinical trials Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 retatrutide safety profile clinical trials

The scale shows similar total loss, but youre losing more muscle and less fat, worsening body composition and metabolic health

However, when the gut is inflamed or imbalanced (a condition known as dysbiosis), GLP-1 production can be impaired

The scale stops moving even at the maximum tirzepatide dose

Losing around one to two pounds each week is ideal, but sometimes youll see more and sometimes, none at all

Well sealed and properly packed

They are particularly useful for people who: Have type 2 diabetes with excess weight Struggle with hypoglycaemia on other therapies Have established cardiovascular disease Want to delay or minimise insulin use Frequently Asked Questions What does GLP-1 stand for